Cargando…
Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database
BACKGROUND: Human epidermal growth factor receptor 2‐positive (HER2+) metastatic breast cancer (MBC) is a subtype of breast cancer with a worse prognosis. Little is known about the relationship between histology and prognosis among different distant metastasis sites (DMS). Our aims were to explore t...
Autores principales: | Wang, Yajie, Liang, Yiran, Ye, Fangzhou, Luo, Dan, Jin, Yuhan, Li, Yaming, Zhao, Wenjing, Chen, Bing, Wang, Lijuan, Yang, Qifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557902/ https://www.ncbi.nlm.nih.gov/pubmed/37605516 http://dx.doi.org/10.1002/cam4.6469 |
Ejemplares similares
-
Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
por: Luo, Dan, et al.
Publicado: (2023) -
CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA
por: Song, Xiaojin, et al.
Publicado: (2022) -
Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication
por: Ye, Fangzhou, et al.
Publicado: (2023) -
HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
por: Liang, Yiran, et al.
Publicado: (2023) -
DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer
por: Liang, Yiran, et al.
Publicado: (2021)